TrialSignal
Clinical trial intelligence report
A Study to Investigate the Safety and Efficacy of a Topical Gentamicin-Collagen Sponge Compared to Levofloxacin in Diabetic Patients With a Mild Infection of a Lower Extremity Skin Ulcer
Source-linked diligence brief with registry provenance, taxonomy normalization and premium analytical context.
Generated
Jun 20, 2026
NCT ID
NCT00593567
Status
COMPLETED
Phase
PHASE2
Sponsor
Innocoll
Executive brief
Investment-Ready Snapshot
The purpose of this study is to determine whether the gentamicin-collagen sponge when combined with standard of daily wound care is safe and effective in treating mildly infected skin ulcers compared to treatment with an oral antibiotic (levofloxacin) and standard daily wound care.
Source & freshness
Provenance
https://clinicaltrials.gov/study/NCT00593567
Indication
Diabetic Foot Ulcer
Modality
small molecule
Target
gentamicin-collagen sponge, Levofloxacin
Intervention
gentamicin-collagen sponge, Levofloxacin
Source record
Protocol Description
Detailed source ingestion pending.
Source record
Outcome Measures
Detailed source ingestion pending.
Source record
Eligibility
Detailed source ingestion pending.
AI analysis
Known Results And Readout Context
Detailed source ingestion pending.
IP intelligence
Patent And IP Landscape
Detailed source ingestion pending.
Source record
Contacts
Detailed source ingestion pending.